NCT00529282View on ClinicalTrials.gov

A Study of Ceftobiprole in Patients With Fever and Neutropenia.

PHASE3TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
FeverNeutropeniaGram-positive Bacterial InfectionsPseudomonas Infection
Interventions
DRUG

Ceftobiprole Medocaril

500 mg every 8 hours

DRUG

Cefepime with or without vancomycin

120-minute infusion \[250 mL\]

Sponsors
All Listed Sponsors
lead

Basilea Pharmaceutica

INDUSTRY

NCT00529282 - A Study of Ceftobiprole in Patients With Fever and Neutropenia. | Biotech Hunter | Biotech Hunter